ArticleCurrent oncology (Toronto, Ont.)2023

Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.

Carlo Signorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.